Oura’s May 2026 confidential S-1 filing and $11 billion private valuation following its $900 million Series E round anchor trader sentiment, with revenue on pace to reach roughly $1.5 billion in 2026 supporting expectations for an IPO later this year. The closely matched probabilities across $7.5–20 billion-plus ranges and the 13.1% chance of no IPO before January 2027 reflect uncertainty over achievable public multiples, broader IPO market conditions, and execution risks in the competitive wearables sector. Institutional underwriters and recent funding momentum suggest a potential premium to the last private mark, yet forward-looking estimates remain sensitive to earnings trajectory and comparable health-tech listings.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano$20B+ 16%
$10B–$12.5B 14%
No IPO before January 2027 13.0%
$15B–$17.5B 12%
$170,753 Wol.
$170,753 Wol.
Jan 1, 2027
<$7.5B
9%
$7.5B–$10B
11%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
12%
$17.5B–$20B
12%
$20B+
16%
No IPO before January 2027
13%
$20B+ 16%
$10B–$12.5B 14%
No IPO before January 2027 13.0%
$15B–$17.5B 12%
$170,753 Wol.
$170,753 Wol.
Jan 1, 2027
<$7.5B
$18,907 Wol.
9%
$7.5B–$10B
$27,466 Wol.
11%
$10B–$12.5B
$22,283 Wol.
14%
$12.5B–$15B
$49,969 Wol.
11%
$15B–$17.5B
$13,741 Wol.
12%
$17.5B–$20B
$16,657 Wol.
12%
$20B+
$16,430 Wol.
16%
No IPO before January 2027
$5,299 Wol.
13%
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura’s May 2026 confidential S-1 filing and $11 billion private valuation following its $900 million Series E round anchor trader sentiment, with revenue on pace to reach roughly $1.5 billion in 2026 supporting expectations for an IPO later this year. The closely matched probabilities across $7.5–20 billion-plus ranges and the 13.1% chance of no IPO before January 2027 reflect uncertainty over achievable public multiples, broader IPO market conditions, and execution risks in the competitive wearables sector. Institutional underwriters and recent funding momentum suggest a potential premium to the last private mark, yet forward-looking estimates remain sensitive to earnings trajectory and comparable health-tech listings.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Rynek otwarty: May 26, 2026, 12:28 PM ET
Wolumen
$170,753Data zakończenia
Jan 1, 2027Rynek otwarty
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura’s May 2026 confidential S-1 filing and $11 billion private valuation following its $900 million Series E round anchor trader sentiment, with revenue on pace to reach roughly $1.5 billion in 2026 supporting expectations for an IPO later this year. The closely matched probabilities across $7.5–20 billion-plus ranges and the 13.1% chance of no IPO before January 2027 reflect uncertainty over achievable public multiples, broader IPO market conditions, and execution risks in the competitive wearables sector. Institutional underwriters and recent funding momentum suggest a potential premium to the last private mark, yet forward-looking estimates remain sensitive to earnings trajectory and comparable health-tech listings.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Wolumen
$170,753Data zakończenia
Jan 1, 2027Rynek otwarty
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...Oura’s May 2026 confidential S-1 filing and $11 billion private valuation following its $900 million Series E round anchor trader sentiment, with revenue on pace to reach roughly $1.5 billion in 2026 supporting expectations for an IPO later this year. The closely matched probabilities across $7.5–20 billion-plus ranges and the 13.1% chance of no IPO before January 2027 reflect uncertainty over achievable public multiples, broader IPO market conditions, and execution risks in the competitive wearables sector. Institutional underwriters and recent funding momentum suggest a potential premium to the last private mark, yet forward-looking estimates remain sensitive to earnings trajectory and comparable health-tech listings.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania